SARS-CoV-2 ORF3a Blocking Peptide for STJ506069 peptide (STJ505810)
SPECIFICATIONS
ImmunogenSynthetic peptide taken from a unique amino acid sequence on ORF3a protein [Severe acute respiratory syndrome coronavirus 2]
General Information
| Short Description | SARS-CoV-2 ORF3a Blocking Peptide for STJ506069 is synthetically produced from the sequence and is suitable for use in western blot applications. |
| Applications | Immunodepletion/Immunocompetition |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Formulation | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction | Store at-20ยฐC for long term storage. Avoid freeze-thaw cycles. |
Target Information
| Immunogen | Synthetic peptide taken from a unique amino acid sequence on ORF3a protein [Severe acute respiratory syndrome coronavirus 2] |
| Specificity | This blocking peptide is recommended for use in combination with SARS-CoV-2 ORF3a antibody, STJ506069 |